Department of General Surgery, The Second Medical Center - National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China.
Department of Internal Medicine, Henan Cancer Hospital, Zhengzhou, China.
Turk J Med Sci. 2022 Aug;52(4):1067-1074. doi: 10.55730/1300-0144.5409. Epub 2022 Aug 10.
Hepatic resection is a potentially curative treatment for patients with hepatocellular carcinoma (HCC). Controversy persists regarding preoperative and intraoperative characteristics related to patient survival in various medical institutes. This study aimed to evaluate the impact of preoperative and intraoperative factors on the long-term survival of patients with HCC who underwent hepatectomy.
Data on 455 patients with HCC who underwent hepatectomy over a 20-year period were retrospectively reviewed. Univariate and multivariate Cox regression analyses were performed for preoperative- and intraoperative-related prognostic factors.
The 1-, 3-, 5-, and 10-year overall survival rates of patients with HCC who underwent resection were 76.3%, 57.9%, 46.7%, and 27.4%, respectively. Multivariate analyses identified four independent predictors of long-term prognosis-sex (male versus female, hazard ratio [HR] = 2.732, p = 0.026); differentiation (poor versus well, HR = 2.037, p = 0.030); total bilirubin value (μmol/L, HR = 1.056, p = 0.033); and intraoperative blood transfusion (no transfusion versus transfusion, HR = 0.417, p = 0.002). Hepatitis virus B infection (negative versus positive, HR = 0.669, p = 0.232) and resection style (anatomical versus nonanatomical, HR = 0.698, p = 0.181) were not associated with survival.
Based on this 20-year study, poor survival of patients with HCC who underwent hepatectomy was correlated with preoperative and intraoperative factors including male sex, poor differentiation, increased total bilirubin levels, and intraoperative blood transfusion.
肝切除术是治疗肝细胞癌(HCC)患者的一种潜在治愈性治疗方法。在不同的医疗机构中,关于与患者生存相关的术前和术中特征仍然存在争议。本研究旨在评估术前和术中因素对接受肝切除术的 HCC 患者长期生存的影响。
回顾性分析了 20 年来接受肝切除术的 455 例 HCC 患者的数据。对术前和术中相关预后因素进行单因素和多因素 Cox 回归分析。
接受切除术的 HCC 患者的 1、3、5 和 10 年总生存率分别为 76.3%、57.9%、46.7%和 27.4%。多因素分析确定了四个独立的长期预后预测因素-性别(男性与女性,风险比[HR] = 2.732,p = 0.026);分化(差与好,HR = 2.037,p = 0.030);总胆红素值(μmol/L,HR = 1.056,p = 0.033);术中输血(无输血与输血,HR = 0.417,p = 0.002)。乙型肝炎病毒感染(阴性与阳性,HR = 0.669,p = 0.232)和切除方式(解剖与非解剖,HR = 0.698,p = 0.181)与生存无关。
基于这项 20 年的研究,接受肝切除术的 HCC 患者的生存率较差与术前和术中因素相关,包括男性、低分化、总胆红素水平升高和术中输血。